Ikarian-Capital

AI_NATIVE detailed information: This accession holds the following tickers:[
  "AKRO",
  "EWTX",
  "TRVI",
  "NKTR",
  "INSM",
  "FBRX",
  "TGTX",
  "APLS",
  "ALNY",
  "ARCT",
  "DNA",
  "SWTX",
  "RCKT",
  "SGMO",
  "ARVN",
  "ALT",
  "RCUS",
  "OLMA",
  "GPCR",
  "RLAY",
  "THRD",
  "TERN",
  "TRML",
  "NUVB",
  "TYRA",
  "MNMD",
  "TECX",
  "LRMR",
  "MLYS",
  "KYMR",
  "NMRA",
  "ABEO",
  "KROS",
  "GLUE",
  "PRTA",
  "ABOS",
  "ANRO",
  "ALEC",
  "ALLK",
  "AVTX",
  "JANX",
  "ANEB",
  "PHGE",
  null,
  "GERN",
  "SRRK",
  "FULC",
  "APGE",
  "TARS",
  "TKNO",
  "INBX",
  "JSPR",
  "MGNX",
  "LXEO",
  "LYEL",
  null,
  "MNPR",
  null,
  "STIM",
  "OKUR",
  "PYXS",
  "RLMD",
  "SGMT",
  "SNSE",
  "SYBX",
  "CYBN",
  null,
  "AEMD",
  "TOVX",
  "RZLT",
  "ACRS",
  "ACOG",
  "INCY",
  "TEVA",
  "SPY",
  "PTGX",
  "PEPG",
  "TRAW",
  "RNA",
  "SLDB",
  "PRAX",
  "LXRX",
  "LYRA",
  "MLTX",
  "IBIO",
  "EVAX",
  "SLNO",
  "ACLX",
  "QURE",
  "RNAC",
  "ETNB",
  "DYN",
  "SPRB",
  "SRPT",
  "CHRO",
  null,
  null,
  "CRVS",
  "CDTX",
  "ELDN",
  "ELEV",
  "ELVN",
  "DCTH",
  "EOLS",
  "IMUX",
  "HROW",
  "HOOK",
  "ITOS",
  "KPTI",
  "KOD",
  "KZR",
  "VRNA",
  "VERU",
  "VTYX",
  "VERV",
  "VTGN",
  "VKTX",
  "VIR",
  "VIGL",
  "VRDN",
  "VYGR",
  "ORKA",
  "BHVN",
  "TRUP",
  "TDOC",
  "RARE",
  "IMVT",
  "PCVX",
  "BPMC",
  "BBIO",
  "CAPR",
  "CELC",
  "CPRX",
  "CLDX",
  "CMPX",
  "CORT",
  "CRNX",
  "CPIX",
  "CYTK",
  "IRON",
  "LLY"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 141
Total Value: 710178588
Accession Number: 0001420506-25-001276
Form Type: 13F-HR
CIK: ikarian-capital
Manager Name: Ikarian-Capital

Data Enrichment

96% identified

135 identified6 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

141 positions • $710.2M total value

141 positions • $710.2M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 4 of 8

Sort by:

Oruka Therapeutics, Inc.

Shares:175.0K

Value:$1.8M

% of Portfolio:0.3% ($1.8M/$710.2M)

Apellis Pharmaceuticals, Inc.

Shares:75.0K

Value:$1.6M

% of Portfolio:0.2% ($1.6M/$710.2M)

Verve Therapeutics, Inc.

Shares:358.4K

Value:$1.6M

% of Portfolio:0.2% ($1.6M/$710.2M)

ARVINAS, INC.

Shares:229.9K

Value:$1.6M

% of Portfolio:0.2% ($1.6M/$710.2M)

Avalo Therapeutics, Inc.

Shares:200.0K

Value:$1.6M

% of Portfolio:0.2% ($1.6M/$710.2M)

Arcturus Therapeutics Holdings Inc.

Shares:150.0K

Value:$1.6M

% of Portfolio:0.2% ($1.6M/$710.2M)

HARROW, INC.

Shares:58.3K

Value:$1.6M

% of Portfolio:0.2% ($1.6M/$710.2M)

Vistagen Therapeutics, Inc.

Shares:601.7K

Value:$1.5M

% of Portfolio:0.2% ($1.5M/$710.2M)

ROCKET PHARMACEUTICALS, INC.

Shares:221.9K

Value:$1.5M

% of Portfolio:0.2% ($1.5M/$710.2M)

Ventyx Biosciences, Inc.

Shares:1.2M

Value:$1.4M

% of Portfolio:0.2% ($1.4M/$710.2M)

Arcus Biosciences, Inc.

Shares:163.4K

Value:$1.3M

% of Portfolio:0.2% ($1.3M/$710.2M)

DELCATH SYSTEMS, INC.

Shares:100.4K

Value:$1.3M

% of Portfolio:0.2% ($1.3M/$710.2M)

Compass Therapeutics, Inc.

Shares:662.2K

Value:$1.3M

% of Portfolio:0.2% ($1.3M/$710.2M)

PROTHENA CORP PUBLIC LTD CO

Shares:100.0K

Value:$1.2M

% of Portfolio:0.2% ($1.2M/$710.2M)

SANGAMO THERAPEUTICS, INC

Shares:1.9M

Value:$1.2M

% of Portfolio:0.2% ($1.2M/$710.2M)

Altimmune, Inc.

Shares:240.0K

Value:$1.2M

% of Portfolio:0.2% ($1.2M/$710.2M)

Teladoc Health, Inc.

Shares:150.0K

Value:$1.2M

% of Portfolio:0.2% ($1.2M/$710.2M)

Alector, Inc.

Shares:950.0K

Value:$1.2M

% of Portfolio:0.2% ($1.2M/$710.2M)

OnKure Therapeutics, Inc.

Shares:253.8K

Value:$1.1M

% of Portfolio:0.2% ($1.1M/$710.2M)

Nuvation Bio Inc.

Shares:619.3K

Value:$1.1M

% of Portfolio:0.2% ($1.1M/$710.2M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Oruka Therapeutics, Inc.(ORKAcusip687604108)	175.0K	QoQ NEW(+175.0K) YoY NEW(+175.0K)	All Managers (Combined)	$1.8M	0.3% ($1.8M/$710.2M)	QoQ NEW(+$1.8M) YoY NEW(+$1.8M)
Apellis Pharmaceuticals, Inc.(APLScusip03753U106)	75.0K	QoQ +1986.81% (+71.4K) YoY -25.00% (-25.0K)	All Managers (Combined)	$1.6M	0.2% ($1.6M/$710.2M)	QoQ +1330.22% (+$1.5M) YoY -72.09% (-$4.2M)
Verve Therapeutics, Inc.(VERVcusip92539P101)	358.4K	QoQ +110.83% (+188.4K) YoY NEW(+358.4K)	All Managers (Combined)	$1.6M	0.2% ($1.6M/$710.2M)	QoQ +70.83% (+$679.1K) YoY NEW(+$1.6M)
ARVINAS, INC.(ARVNcusip04335A105)	229.9K	QoQ NEW(+229.9K) YoY NEW(+229.9K)	All Managers (Combined)	$1.6M	0.2% ($1.6M/$710.2M)	QoQ NEW(+$1.6M) YoY NEW(+$1.6M)
Avalo Therapeutics, Inc.(AVTXcusip05338F306)	200.0K	QoQ -79.38% (-770.3K) YoY +328.74% (+153.4K)	All Managers (Combined)	$1.6M	0.2% ($1.6M/$710.2M)	QoQ -77.77% (-$5.6M) YoY +57.89% (+$587.4K)
Arcturus Therapeutics Holdings Inc.(ARCTcusip03969T109)	150.0K	QoQ -25.00% (-50.0K) YoY NEW(+150.0K)	All Managers (Combined)	$1.6M	0.2% ($1.6M/$710.2M)	QoQ -53.19% (-$1.8M) YoY NEW(+$1.6M)
HARROW, INC.(HROWcusip415858109)	58.3K	QoQ 0.00% (-0) YoY NEW(+58.3K)	All Managers (Combined)	$1.6M	0.2% ($1.6M/$710.2M)	QoQ -20.71% (-$405.2K) YoY NEW(+$1.6M)
Vistagen Therapeutics, Inc.(VTGNcusip92840H400)	601.7K	QoQ +675.23% (+524.1K) YoY NEW(+601.7K)	All Managers (Combined)	$1.5M	0.2% ($1.5M/$710.2M)	QoQ +556.97% (+$1.3M) YoY NEW(+$1.5M)
ROCKET PHARMACEUTICALS, INC.(RCKTcusip77313F106)	221.9K	QoQ 0.00% (-0) YoY -25.30% (-75.2K)	All Managers (Combined)	$1.5M	0.2% ($1.5M/$710.2M)	QoQ -46.93% (-$1.3M) YoY -81.50% (-$6.5M)
Ventyx Biosciences, Inc.(VTYXcusip92332V107)	1.2M	QoQ +11.44% (-125.0K) YoY +139.84% (-709.9K)	All Managers (Combined)	$1.4M	0.2% ($1.4M/$710.2M)	QoQ -41.48% (-$992.5K) YoY -49.84% (-$1.4M)
Arcus Biosciences, Inc.(RCUScusip03969F109)	163.4K	QoQ -56.82% (-215.0K) YoY NEW(+163.4K)	All Managers (Combined)	$1.3M	0.2% ($1.3M/$710.2M)	QoQ -77.23% (-$4.4M) YoY NEW(+$1.3M)
DELCATH SYSTEMS, INC.(DCTHcusip24661P807)	100.4K	QoQ 0.00% (+0) YoY NEW(+100.4K)	All Managers (Combined)	$1.3M	0.2% ($1.3M/$710.2M)	QoQ +5.73% (+$69.3K) YoY NEW(+$1.3M)
Compass Therapeutics, Inc.(CMPXcusip20454B104)	662.2K	QoQ NEW(+662.2K) YoY NEW(+662.2K)	All Managers (Combined)	$1.3M	0.2% ($1.3M/$710.2M)	QoQ NEW(+$1.3M) YoY NEW(+$1.3M)
PROTHENA CORP PUBLIC LTD CO(PRTAcusipG72800108)	100.0K	QoQ NEW(+100.0K) YoY NEW(+100.0K)	All Managers (Combined)	$1.2M	0.2% ($1.2M/$710.2M)	QoQ NEW(+$1.2M) YoY NEW(+$1.2M)
SANGAMO THERAPEUTICS, INC(SGMOcusip800677106)	1.9M	QoQ 0.00% (-0) YoY NEW(+1.9M)	All Managers (Combined)	$1.2M	0.2% ($1.2M/$710.2M)	QoQ -35.70% (-$677.5K) YoY NEW(+$1.2M)
Altimmune, Inc.(ALTcusip02155H200)	240.0K	QoQ +44.84% (+74.3K) YoY NEW(+240.0K)	All Managers (Combined)	$1.2M	0.2% ($1.2M/$710.2M)	QoQ +0.44% (+$5.3K) YoY NEW(+$1.2M)
Teladoc Health, Inc.(TDOCcusip87918A105)	150.0K	QoQ NEW(+150.0K) YoY NEW(+150.0K)	All Managers (Combined)	$1.2M	0.2% ($1.2M/$710.2M)	QoQ NEW(+$1.2M) YoY NEW(+$1.2M)
Alector, Inc.(ALECcusip014442107)	950.0K	QoQ 0.00% (-0) YoY NEW(+950.0K)	All Managers (Combined)	$1.2M	0.2% ($1.2M/$710.2M)	QoQ -34.92% (-$627.0K) YoY NEW(+$1.2M)
OnKure Therapeutics, Inc.(OKURcusip68277Q105)	253.8K	QoQ 0.00% (-0) YoY NEW(+253.8K)	All Managers (Combined)	$1.1M	0.2% ($1.1M/$710.2M)	QoQ -49.99% (-$1.1M) YoY NEW(+$1.1M)
Nuvation Bio Inc.(NUVBcusip67080N101)	619.3K	QoQ +642.45% (+535.9K) YoY -2.21% (-14.0K)	All Managers (Combined)	$1.1M	0.2% ($1.1M/$710.2M)	QoQ +391.24% (+$868.0K) YoY -52.71% (-$1.2M)